The Cancer Research editors proudly present this collection of recently published papers highlighting research in stemness, genomics, immunity, and therapeutics in hematologic malignancies.
-
CBP Modulates Sensitivity to Dasatinib in pre-BCR+ Acute Lymphoblastic Leukemia
Duque-Afonso J Cleary ML. Cancer Research November 15 2018 -
Development, Function and Clinical Significance of Plasmacytoid Dendritic Cells in Chronic Myeloid Leukemia
Inselmann S Burchert A. Cancer Research November 1 2018 -
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes
Wang SS Skibola CF. Cancer Research July 15 2018 -
MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis
Trissal MC Link DC. Cancer Research July 1 2018 -
miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the BCL2L11 and BAX Proapoptotic Genes
Hu T Cowell JK. Cancer Research July 1 2018 -
Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma
Wei X Lipkin SM. Cancer Research May 15 2018 -
From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cell
van Nieuwenhuijzen N Peperzak V. Cancer Research May 15 2018 -
Antitumor Effects of Blocking Protein Neddylation in T315I-BCR-ABL Leukemia Cells and Leukemia Stem Cells
Liu C Pan J. Cancer Research March 15 2018 -
Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression
De Smedt E De Bruyne E. Cancer Research March 1 2018 -
Targeting CDK6 and BCL2 Exploits the "MYB Addiction" of Ph+ Acute Lymphoblastic Leukemia
De Dominici M Calabretta B. Cancer Research February 15 2018 -
Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy
Taylor A Rudd CE. Cancer Research February 1 2018 -
An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma
Silva A Shain KH. Cancer Research June 15 2017 -
STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy
Dahal LN Beers SA. Cancer Research July 1 2017 -
Effective Combination Therapies for B-cell Lymphoma Predicted by a Virtual Disease Model
Du W Elemento O. Cancer Research April 15 2017 -
Histone Acetyltransferase Activity of MOF Is Required for MLL-AF9 Leukemogenesis
Valerio DG Armstrong SA. Cancer Research April 1 2017 -
Biomarker Dynamics in B-cell Lymphoma: A Longitudinal Prospective Study of Plasma Samples Up to 25 Years before Diagnosis
Späth F Melin B. Cancer Research March 15 2017 -
Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3
Hiasa M Yoneda T. Cancer Research March 15 2017 -
Finally, An Apoptosis-Targeting Therapeutic for Cancer
Croce CM and Reed JC. Cancer Research October 15 2016 -
Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles
Jiang X Chen J. Cancer Research August 1 2016 -
Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
Zhao JJ Carrasco RD. Cancer Research October 15 2015
Cancer Research Editorial Office
American Association for Cancer Research | Publications Division
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215) 440-9300 | Fax: (215) 440-9354 | E-mail: cancerres@aacr.org